Drug Search Results
Using advanced filters...
Advanced Search [+]

Erdosteine

Alternative Names: erdosteine
Latest Update: 2024-10-31
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Bangladesh | Belgium | Brazil | Bulgaria | Chile | Colombia | Czech | Egypt | Finland | France | Germany | Greece | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Luxembourg | Malaysia | Mexico | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Singapore | Slovakia | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Edmond Pharma
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Chronic Obstructive Pulmonary Disease|Skin Diseases, Genetic|Bronchiectasis

Phase 3: Chronic Obstructive Pulmonary Disease

Phase 2: Bronchitis, Chronic|Chronic Obstructive Pulmonary Disease

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12624001381572

P4

Not yet recruiting

Bronchiectasis

2025-07-17

BETTER

P4

Recruiting

Bronchiectasis

2024-09-13

REPEAT Study

P4

Completed

Skin Diseases, Genetic

2023-04-04

ChiCTR2100054291

N/A

Recruiting

Healthy Volunteers

2022-01-31

Recent News Events